Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/14/1998 | EP0870500A1 Anti-helicobacter pylori agent |
10/14/1998 | EP0870499A1 Oral use of (+)-0-Demethyltramadol as analgesic |
10/14/1998 | EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
10/14/1998 | EP0870049A2 Complementary adenoviral vector systems and cell lines |
10/14/1998 | EP0870046A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
10/14/1998 | EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin |
10/14/1998 | EP0870036A1 SYNTHETIC MAMMALIAN $g(a)-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
10/14/1998 | EP0870035A2 A novel protein kinase required for ras signal transduction |
10/14/1998 | EP0870034A1 Novel nagpu |
10/14/1998 | EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
10/14/1998 | EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2 |
10/14/1998 | EP0870026A1 Ob protein derivatives having prolonged half-life |
10/14/1998 | EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
10/14/1998 | EP0870022A1 Immunostimulatory composition and method |
10/14/1998 | EP0870019A2 Cell activation process and reagents therefor |
10/14/1998 | EP0870018A1 Antitumour vector constructs and methods |
10/14/1998 | EP0869975A1 Assay for and uses of peptide hormone receptor ligands |
10/14/1998 | EP0869974A1 Compounds with growth hormone releasing properties |
10/14/1998 | EP0869972A1 Chemokine from niddm pancreas |
10/14/1998 | EP0869971A1 Two component signal transducing system protein from staphylococcus aureus |
10/14/1998 | EP0869968A1 Growth-hormone secretagogues |
10/14/1998 | EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
10/14/1998 | EP0869966A1 Prodrugs of thrombin inhibitors |
10/14/1998 | EP0869965A1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
10/14/1998 | EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives |
10/14/1998 | EP0869957A2 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
10/14/1998 | EP0869956A1 Pharmaceutical compositions |
10/14/1998 | EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/14/1998 | EP0869954A1 Novel heterocyclic compounds |
10/14/1998 | EP0869953A1 Nucleoside derivatives and process for preparing thereof |
10/14/1998 | EP0869952A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
10/14/1998 | EP0869949A1 Benzoxazine antimicrobial agents |
10/14/1998 | EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
10/14/1998 | EP0869946A1 Phenylimidazolidines and use thereof as an antiandrogenic agent |
10/14/1998 | EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents |
10/14/1998 | EP0869944A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS |
10/14/1998 | EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
10/14/1998 | EP0869942A1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
10/14/1998 | EP0869941A1 Modified polyunsaturated fatty acids |
10/14/1998 | EP0869819A1 Pharmaceutical compositions with vitamin d analogues |
10/14/1998 | EP0869818A1 Cytotoxic agents |
10/14/1998 | EP0869817A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
10/14/1998 | EP0869815A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
10/14/1998 | EP0869814A1 Stabilisers for live vaccines |
10/14/1998 | EP0869813A1 Method of using beta-interferons to treat restenosis |
10/14/1998 | EP0869807A2 Use of a medicament and use of mixture of substances to produce a medicament |
10/14/1998 | EP0869806A1 A pharmaceutical composition comprising plant worms and muirapuama |
10/14/1998 | EP0869805A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
10/14/1998 | EP0869803A1 Allogeneic paracrine cytokine tumor vaccines |
10/14/1998 | EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
10/14/1998 | EP0869801A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
10/14/1998 | EP0869798A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
10/14/1998 | EP0869797A2 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
10/14/1998 | EP0869796A1 A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii |
10/14/1998 | EP0869795A1 Otic microbial combinations |
10/14/1998 | EP0869794A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
10/14/1998 | EP0869793A1 Hemoregulatory compounds |
10/14/1998 | EP0869791A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
10/14/1998 | EP0869790A1 THIENO(2,3-b)PYRAZOLO(3,4-d)PYRIDIN-3-ONES TO ENHANCE ERYTHROPOIESIS |
10/14/1998 | EP0869789A1 Antiviral agent |
10/14/1998 | EP0869788A1 Compositions for the treatment of renal failure, comprising l-carnosine |
10/14/1998 | EP0869787A1 Vitronectin receptor antagonists |
10/14/1998 | EP0869786A1 Pharmaceutical compounds |
10/14/1998 | EP0869785A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus |
10/14/1998 | EP0869784A1 Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
10/14/1998 | EP0869783A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
10/14/1998 | EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
10/14/1998 | EP0869781A1 Transdermal device for the delivery of flurbiprofen |
10/14/1998 | EP0869780A1 Method for inhibiting generation of free-radicals |
10/14/1998 | EP0869779A1 USE OF INHIBITORS OF THE CELLULAR Na?+ /H?+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION |
10/14/1998 | EP0869778A1 Improved perfluorocarbons for biological gas exchange and method |
10/14/1998 | EP0869777A1 Novel method |
10/14/1998 | EP0869775A1 Dietary fiber delivery system |
10/14/1998 | EP0869773A1 Archaeosomes, archaeosomes containing coenzyme q 10?, and other types of liposomes containing coenzyme q 10? as adjuvants and as delivery vehicles |
10/14/1998 | EP0869771A1 A cosmetic composition and a method for reducing the ageing processes of skin |
10/14/1998 | EP0869767A1 Cosmetic compositions for the hair or skin based on sulfone copolyesters with polyorganosiloxane units |
10/14/1998 | EP0856312B1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder |
10/14/1998 | EP0855911A4 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
10/14/1998 | EP0841912A4 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines |
10/14/1998 | EP0806947A4 Formulations and methods for reducing skin irritation |
10/14/1998 | EP0755380B1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same |
10/14/1998 | EP0752982B1 Biphenyl derivatives as 5ht1d antagonists |
10/14/1998 | EP0750493B1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
10/14/1998 | EP0695293B1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents |
10/14/1998 | EP0689424B1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
10/14/1998 | EP0684811B1 Use of diglycerine esters against skin impurities |
10/14/1998 | EP0678090B1 Piperazine derivatives |
10/14/1998 | EP0673366B1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
10/14/1998 | EP0661968B1 Pharmaceutical composition containing carbachol and other cholinergic substances |
10/14/1998 | EP0657163B1 Antitussive |
10/14/1998 | EP0656881B1 Ester and combinations of an organic nitrate and a salicylate |
10/14/1998 | EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis |
10/14/1998 | EP0577847B1 Morphinan derivative and medicinal use |
10/14/1998 | EP0544905B1 Antibacterial penem compounds |
10/14/1998 | EP0543861B1 Imidazopyridine derivatives, process for their preparation and their application |
10/14/1998 | CN1196089A DNA polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
10/14/1998 | CN1196086A Enamel matrix related polypeptide |
10/14/1998 | CN1196059A Therapeutic compounds |
10/14/1998 | CN1196058A Process for preparation of erythromycin derivatives |
10/14/1998 | CN1196057A Substituted phosphinic compounds and their use as pharmaceuticals |